These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 30991063)
41. Elimination of the listeriolysin O-directed immune response by conservative alteration of the immunodominant listeriolysin O amino acid 91 to 99 epitope. Bouwer HG; Moors M; Hinrichs DJ Infect Immun; 1996 Sep; 64(9):3728-35. PubMed ID: 8751922 [TBL] [Abstract][Full Text] [Related]
42. Down-regulation of acid sphingomyelinase and neutral sphingomyelinase-2 inversely determines the cellular resistance to plasmalemmal injury by pore-forming toxins. Schoenauer R; Larpin Y; Babiychuk EB; Drücker P; Babiychuk VS; Avota E; Schneider-Schaulies S; Schumacher F; Kleuser B; Köffel R; Draeger A FASEB J; 2019 Jan; 33(1):275-285. PubMed ID: 29979630 [TBL] [Abstract][Full Text] [Related]
43. Listeria monocytogenes induces T cell receptor unresponsiveness through pore-forming toxin listeriolysin O. Gekara NO; Zietara N; Geffers R; Weiss S J Infect Dis; 2010 Dec; 202(11):1698-707. PubMed ID: 20961225 [TBL] [Abstract][Full Text] [Related]
44. Development of a single-gene, signature-tag-based approach in combination with alanine mutagenesis to identify listeriolysin O residues critical for the in vivo survival of Listeria monocytogenes. Melton-Witt JA; McKay SL; Portnoy DA Infect Immun; 2012 Jun; 80(6):2221-30. PubMed ID: 22451517 [TBL] [Abstract][Full Text] [Related]
45. Effect of listeriolysin O-loaded erythrocytes on Mycobacterium avium replication within macrophages. Rossi L; Brandi G; Malatesta M; Serafini S; Pierigé F; Celeste AG; Schiavano GF; Gazzanelli G; Magnani M J Antimicrob Chemother; 2004 May; 53(5):863-6. PubMed ID: 15056645 [TBL] [Abstract][Full Text] [Related]
46. Purification and characterization of a recombinant listeriolysin O expressed in Escherichia coli and possible diagnostic applications. Giammarini C; Andreoni F; Amagliani G; Casiere A; Barocci S; Magnani M J Biotechnol; 2004 Apr; 109(1-2):13-20. PubMed ID: 15063610 [TBL] [Abstract][Full Text] [Related]
47. Relative Roles of Listeriolysin O, InlA, and InlB in Listeria monocytogenes Uptake by Host Cells. Phelps CC; Vadia S; Arnett E; Tan Y; Zhang X; Pathak-Sharma S; Gavrilin MA; Seveau S Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30061379 [No Abstract] [Full Text] [Related]
48. Listeriolysin is a potent inducer of the phosphatidylinositol response and lipid mediator generation in human endothelial cells. Sibelius U; Rose F; Chakraborty T; Darji A; Wehland J; Weiss S; Seeger W; Grimminger F Infect Immun; 1996 Feb; 64(2):674-6. PubMed ID: 8550226 [TBL] [Abstract][Full Text] [Related]
49. Listeriolysin O-liposome-mediated cytosolic delivery of macromolecule antigen in vivo: enhancement of antigen-specific cytotoxic T lymphocyte frequency, activity, and tumor protection. Mandal M; Lee KD Biochim Biophys Acta; 2002 Jun; 1563(1-2):7-17. PubMed ID: 12007619 [TBL] [Abstract][Full Text] [Related]
50. Enhanced cytosolic delivery of plasmid DNA by a sulfhydryl-activatable listeriolysin O/protamine conjugate utilizing cellular reducing potential. Saito G; Amidon GL; Lee KD Gene Ther; 2003 Jan; 10(1):72-83. PubMed ID: 12525839 [TBL] [Abstract][Full Text] [Related]
51. Listeriolysin O Regulates the Expression of Optineurin, an Autophagy Adaptor That Inhibits the Growth of Listeria monocytogenes. Puri M; La Pietra L; Mraheil MA; Lucas R; Chakraborty T; Pillich H Toxins (Basel); 2017 Sep; 9(9):. PubMed ID: 28872615 [TBL] [Abstract][Full Text] [Related]
52. Triple negative breast cancers express receptors for LHRH and are potential therapeutic targets for cytotoxic LHRH-analogs, AEZS 108 and AEZS 125. Seitz S; Buchholz S; Schally AV; Weber F; Klinkhammer-Schalke M; Inwald EC; Perez R; Rick FG; Szalontay L; Hohla F; Segerer S; Kwok CW; Ortmann O; Engel JB BMC Cancer; 2014 Nov; 14():847. PubMed ID: 25410881 [TBL] [Abstract][Full Text] [Related]
53. [Construction, expression and refolding of recombinant luteinizing hormone releasing hormone-angiogenin toxin]. Ni ZL; Zhang QH; Qu QY; Lü HL; Fan SY; Cai C Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Aug; 45(8):680-4. PubMed ID: 21055247 [TBL] [Abstract][Full Text] [Related]
54. Production and characterization of neutralizing and nonneutralizing monoclonal antibodies against listeriolysin O. Nato F; Reich K; Lhopital S; Rouyre S; Geoffroy C; Mazie JC; Cossart P Infect Immun; 1991 Dec; 59(12):4641-6. PubMed ID: 1937824 [TBL] [Abstract][Full Text] [Related]
55. LHRH-Targeted Drug Delivery Systems for Cancer Therapy. Li X; Taratula O; Taratula O; Schumann C; Minko T Mini Rev Med Chem; 2017; 17(3):258-267. PubMed ID: 27739358 [TBL] [Abstract][Full Text] [Related]
57. Inhibition of listeriolysin O-induced hemolysis by bovine lactoferrin. Moriishi K; Inoue S; Koura M; Amano F Biol Pharm Bull; 1999 Nov; 22(11):1167-72. PubMed ID: 10598021 [TBL] [Abstract][Full Text] [Related]
58. Crystal structure of listeriolysin O reveals molecular details of oligomerization and pore formation. Köster S; van Pee K; Hudel M; Leustik M; Rhinow D; Kühlbrandt W; Chakraborty T; Yildiz Ö Nat Commun; 2014 Apr; 5():3690. PubMed ID: 24751541 [TBL] [Abstract][Full Text] [Related]
59. Role of bacterial hemolysin production in induction of macrophage Ia expression during infection with Listeria monocytogenes. Marshall NE; Ziegler HK J Immunol; 1991 Oct; 147(7):2324-32. PubMed ID: 1918964 [TBL] [Abstract][Full Text] [Related]
60. Induction of protective T cells against Listeria monocytogenes in mice by immunization with a listeriolysin O-negative avirulent strain of bacteria and liposome-encapsulated listeriolysin O. Tanabe Y; Xiong H; Nomura T; Arakawa M; Mitsuyama M Infect Immun; 1999 Feb; 67(2):568-75. PubMed ID: 9916060 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]